Osiris Therapeutics, Inc. , the leading company focused on developing and marketing stem cell products to treat serious medical conditions, announced today the successful conclusion of a patent challenge in Australia by an opponent whose identity under Australian law was not disclosed.
http://www.biospace.com/news_story.aspx?StoryID=287975&full=1
http://www.biospace.com/news_story.aspx?StoryID=287975&full=1
No comments:
Post a Comment